OPKO Health Total Liabilities 2010-2025 | OPK
OPKO Health total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
| OPKO Health Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $835 |
| 2023 | $622 |
| 2022 | $606 |
| 2021 | $715 |
| 2020 | $802 |
| 2019 | $695 |
| 2018 | $660 |
| 2017 | $746 |
| 2016 | $675 |
| 2015 | $819 |
| 2014 | $432 |
| 2013 | $519 |
| 2012 | $111 |
| 2011 | $69 |
| 2010 | $55 |
| 2009 | $56 |
| OPKO Health Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $817 |
| 2024-12-31 | $835 |
| 2024-09-30 | $853 |
| 2024-06-30 | $585 |
| 2024-03-31 | $721 |
| 2023-12-31 | $622 |
| 2023-09-30 | $612 |
| 2023-06-30 | $624 |
| 2023-03-31 | $618 |
| 2022-12-31 | $606 |
| 2022-09-30 | $596 |
| 2022-06-30 | $651 |
| 2022-03-31 | $692 |
| 2021-12-31 | $715 |
| 2021-09-30 | $652 |
| 2021-06-30 | $679 |
| 2021-03-31 | $823 |
| 2020-12-31 | $802 |
| 2020-09-30 | $748 |
| 2020-06-30 | $735 |
| 2020-03-31 | $684 |
| 2019-12-31 | $695 |
| 2019-09-30 | $728 |
| 2019-06-30 | $747 |
| 2019-03-31 | $813 |
| 2018-12-31 | $660 |
| 2018-09-30 | $692 |
| 2018-06-30 | $720 |
| 2018-03-31 | $756 |
| 2017-12-31 | $746 |
| 2017-09-30 | $633 |
| 2017-06-30 | $662 |
| 2017-03-31 | $653 |
| 2016-12-31 | $675 |
| 2016-09-30 | $695 |
| 2016-06-30 | $758 |
| 2016-03-31 | $795 |
| 2015-12-31 | $819 |
| 2015-09-30 | $1,046 |
| 2015-06-30 | $699 |
| 2015-03-31 | $700 |
| 2014-12-31 | $432 |
| 2014-09-30 | $408 |
| 2014-06-30 | $414 |
| 2014-03-31 | $524 |
| 2013-12-31 | $519 |
| 2013-09-30 | $515 |
| 2013-06-30 | $329 |
| 2013-03-31 | $334 |
| 2012-12-31 | $111 |
| 2012-09-30 | $104 |
| 2012-06-30 | $79 |
| 2012-03-31 | $77 |
| 2011-12-31 | $69 |
| 2011-09-30 | $49 |
| 2011-06-30 | $49 |
| 2011-03-31 | $53 |
| 2010-12-31 | $55 |
| 2010-09-30 | $48 |
| 2010-06-30 | $18 |
| 2010-03-31 | $31 |
| 2009-12-31 | $56 |
| 2009-09-30 | $19 |
| 2009-06-30 | $21 |
| 2009-03-31 | $27 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.023B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $187.481B | 82.12 |
| Thermo Fisher Scientific (TMO) | United States | $152.647B | 18.46 |
| Edwards Lifesciences (EW) | United States | $44.494B | 29.17 |
| Alcon (ALC) | Switzerland | $43.016B | 29.07 |
| IDEXX Laboratories (IDXX) | United States | $42.664B | 49.03 |
| DexCom (DXCM) | United States | $34.337B | 53.07 |
| IQVIA Holdings (IQV) | United States | $27.434B | 15.37 |
| Mettler-Toledo (MTD) | United States | $24.631B | 29.29 |
| STERIS (STE) | Ireland | $23.569B | 25.96 |
| Waters (WAT) | United States | $20.638B | 29.12 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.019B | 0.00 |
| Hologic (HOLX) | United States | $14.447B | 15.70 |
| Sysmex ADR (SSMXY) | Japan | $10.802B | 30.64 |
| Penumbra (PEN) | United States | $9.903B | 77.73 |
| Masimo (MASI) | United States | $9.232B | 34.05 |
| Globus Medical (GMED) | United States | $7.941B | 18.92 |
| Glaukos (GKOS) | United States | $5.725B | 0.00 |
| Teleflex (TFX) | United States | $5.307B | 8.76 |
| TransMedics (TMDX) | United States | $4.486B | 97.53 |
| Integer Holdings (ITGR) | United States | $4.202B | 22.01 |
| PROCEPT BioRobotics (PRCT) | United States | $3.261B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.510B | 14.94 |
| Veracyte (VCYT) | United States | $2.105B | 29.54 |
| Nihon Kohden (NHNKY) | Japan | $1.997B | 22.90 |
| Elekta AB (EKTAY) | Sweden | $1.910B | 17.17 |
| Alphatec Holdings (ATEC) | United States | $1.659B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.344B | 0.00 |
| Artivion (AORT) | United States | $1.328B | 124.44 |
| Pulse Biosciences (PLSE) | United States | $1.036B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.922B | 4.91 |
| IRadimed (IRMD) | United States | $0.769B | 39.02 |
| SiBone (SIBN) | United States | $0.760B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.682B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 8.91 |
| RxSight (RXST) | United States | $0.557B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.538B | 12.61 |
| OrthoPediatrics (KIDS) | United States | $0.520B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.483B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.467B | 12.43 |
| AxoGen (AXGN) | United States | $0.462B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.430B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.411B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.372B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.360B | 0.00 |
| NeuroPace (NPCE) | United States | $0.353B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.326B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.241B | 14.61 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Neuronetics (STIM) | United States | $0.233B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.227B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.220B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.209B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.168B | 0.00 |
| CVRx (CVRX) | United States | $0.158B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.148B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Accuray (ARAY) | United States | $0.135B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 47.10 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.065B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.89 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |